Skip to main content
SpringerLink
Log in

Kidney Tumors Laser Ablation

  • Chapter
  • First Online:
Image-guided Laser Ablation

  • 519 Accesses

Abstract

Cryoablation, radiofrequency ablation, and in a lesser degree microwave ablation are the ablative techniques currently used worldwide to treat small renal tumors, whereas the experience with laser ablation is quite limited. However, the multifiber technique allows for the use of very thin needles to introduce the laser fibers into the tumor, and its lower invasiveness in comparison with the other ablative techniques makes laser ablation an interesting option to treat small renal cell carcinomas, as the kidney is a hypervascular organ and is considered more at-risk of bleeding than the liver or other organs when interventional procedures are performed. A recent retrospective study has documented the very good efficacy and safety of laser ablation in patients with renal tumors and increased risk of bleeding. Despite the limited experience, laser ablation appears to be a promising technique for the treatment of renal cell carcinoma, in particular, in at-risk patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. http://seer.cancer.gov/statfacts/html/kidrp.html. Accessed Nov 2015.

  2. Capitanio U, Montorsi F. Renal cancer. Lancet. 2015;387(10021):894–906.

    Article  Google Scholar 

  3. McKiernan J, Simmons R, Kats J, Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2002;59:816–20.

    Article  Google Scholar 

  4. Krokidis ME, Orsi F, Katsanos K, Helmberger T, Adam A. CIRSE guidelines on percutaneous ablation of small renal cell carcinoma. Cardiovasc Intervent Radiol. 2017;40:177–91.

    Article  Google Scholar 

  5. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy vs. radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes? J Urol. 2009;181(1):55–61.

    Article  Google Scholar 

  6. Zini L, Perrotte P, Capitanio U, Jeldres C, Shariat SF, Antebi E, et al. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer. 2009;115(7):1465–71.

    Article  Google Scholar 

  7. Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, et al. Radical nephrectomy for T1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008;179(2):468–71.

    Article  Google Scholar 

  8. Patard JJ, Bensalah KC, Pantuck AJ, Klatte T, Crepel M, Verhoest G, et al. Radical nephrectomy is not superior to nephron sparing surgery in PT1B-PT2N0M0 renal tumors: a matched comparison analysis in 546 cases. Eur Urol Suppl. 2008;7(3):194.

    Article  Google Scholar 

  9. Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–24.

    Article  Google Scholar 

  10. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175(2):425–31.

    Article  Google Scholar 

  11. Rais-Bahrami S, Guzzo TJ, Jarrett TW, Kavoussi LR, Allf ME. Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention. BJU Int. 2009;103:1355–8.

    Article  Google Scholar 

  12. Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasms: further observations on growth. Radiology. 1995;197:589–97.

    Article  CAS  Google Scholar 

  13. Oda T, Miyao N, Takahashi A, Yanase M, Masumori N, Itoh N, et al. Growth raters of primary and metastatic lesions of renal cell carcinoma. Int J Urol. 2001;8:473–7.

    Article  CAS  Google Scholar 

  14. Gudmundsson E, Hellborg H, Lundstam S, Erikson S, Ljungberg B, Swedish Kidney Cancer Quality Register Group. Metastastic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data. Eur Urol. 2011;60(5):975–82.

    Article  Google Scholar 

  15. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma. Part 1. Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR. 2005;185:64–71.

    Article  Google Scholar 

  16. Georgiades CS, Rodriguez R. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study. Cardiovasc Intervent Radiol. 2014;37(6):1494–9.

    Article  Google Scholar 

  17. Breen D, Bryant TJ, Abbas A, Shepherd B, McGill N, Andreson JA, et al. Percutaneous cryoablation of renal tumors: outcomes from 171 tumors in 147 patients. BJU Int. 2013;112(6):758–65.

    Article  Google Scholar 

  18. McDermott S, Gervais DA. Radiofrequency ablation of liver tumors. Semin InterventRadiol. 2013;30(1):49–55.

    Article  Google Scholar 

  19. Escudier B, Porta C, Schmidinger M, Algaba F, PAtard JJ, Khoo V, et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(3):49–56.

    Article  Google Scholar 

  20. Ma Y, Bedir S, Cadeddu JA, Gahan JC. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumors. BJU Int. 2014;113:51–5.

    Article  Google Scholar 

  21. Boutros C, Somasundar P, Garrean S, Saied A, Espat NJ. Microwave coagulation therapy for hepatic tumors: review of the literature and critical analysis. Surg Oncol. 2010;19:e22–32.

    Article  CAS  Google Scholar 

  22. Lubner MG, Brace CL, Ziemlewicz TJ, Hinshaw JL, Lee FT Jr. Microwave ablation of hepatic malignancy. Semin Intervent Radiol. 2013;30:56–66.

    Article  Google Scholar 

  23. Di Vece F, Tombesi P, Ermili F, Maraldi C, Sartori S. Coagulation areas produced by cool-tip radiofrequency ablation and microwave ablation using a device to decrease back-heating effects: a prospective pilot study. Cardiovasc InterventRadiol. 2014;37:723–9.

    Google Scholar 

  24. Knavel EM, Hinshaw JL, Lubner MG, Andreano A, Thomas FW, Lee FT Jr, et al. High-powered gas-cooled microwave ablation: shaft cooling creates an effective stick function without altering the ablation zone. AJR Am J Roentgenol. 2012;198:W260–5.

    Article  Google Scholar 

  25. Horn JC, Patel RS, Kim E, Nowakowski FS, Lookstein RA, Fischman AM. Percutaneous microwave ablation of renal tumors using a gas-cooled 2.4-Gh probe: technique and initial results. J Vasc Intervent Radiol. 2014;25:448–53.

    Article  Google Scholar 

  26. Pacella CM, Francica G, Di Lascio FM, Arienti V, Antico E, Caspani B, et al. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis. J Clin Oncol. 2009;27:2615–21.

    Article  Google Scholar 

  27. Ferrari FS, Megliola A, Scorzelli A, Stella A, Vigni F, Drudi FM, et al. Treatment of small HCC through radiofrequency ablation and laser ablation. Comparison of techniques and long-term results. Radiol Med. 2007;112:377–93.

    Article  CAS  Google Scholar 

  28. Puls R, Langner S, Rosenberg C, Hegenscheid K, Kuehn JP, Noeckler K, et al. Laser ablation of liver metastases from colorectal cancer with MR thermometry: 5-year survival. J Vasc Radiol. 2009;20:225–34.

    Article  Google Scholar 

  29. Di Costanzo GG, Tortora R, D’Adamo G, De Luca M, Lampasi F, Addario L, et al. Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial. J Gastroenterol Hepatol. 2015;30:559–65.

    Article  Google Scholar 

  30. Sartori S, Di Vece F, Ermili F, Tombesi P. Laser ablation of liver tumors: an ancillary technique, or an alternative to radiofrequency and microwave? World J Radiol. 2017;9(3):91–6.

    Article  Google Scholar 

  31. Karinimi J, Ojala R, Hellstrom P, Sequeros RB. MRI-guided percutaneous laser ablation of small renal cell carcinoma: Initial clinical experience. Acta Radiol. 2010;51:467–72.

    Article  Google Scholar 

  32. De Jode MG, Vale JA, Gedroyc WM. MR-guided laser thermoablation of inoperable renal tumors in an open-configuration interventional MR scanner: preliminary clinical experience in three cases. J Magn Reson Imaging. 1999;10:545–9.

    Article  Google Scholar 

  33. Dick EA, Joarder R, De Jode MG, Wragg P, Vale JA, Gedroyc WM. Magnetic resonance imaging-guided laser thermal ablation of renal tumors. BJU Int. 2002;90:814–22.

    Article  CAS  Google Scholar 

  34. Giesbrandt K, Walser E. MR imaging-guided laser ablation of hepatic and renal tumors. AJR Am J Roentgenol. 2012;198:E642.

    Google Scholar 

  35. Huang GT, Wang TH, Sheu JC, Daikuzono N, Sung JL, Wu MZ, et al. Low-power laserthermia for the treatment of small hepatocellular carcinoma. Eur J Cancer. 1991;27:1622–7.

    Article  CAS  Google Scholar 

  36. Muralidharan V, Malcontenti-Wilson C, Christophi C. Interstitial laser hyperthermia for colorectal liver metastases: the effect of thermal sensitization and the use of a cylindrical diffuser tip on tumor necrosis. J Clin Laser Med Surg. 2002;20:189–96.

    Article  CAS  Google Scholar 

  37. Vogl TJ, Straub R, Zangos S, Mack MG, Eichler K. MR-guided laser induced thermotherapy (LITT) of liver tumours: experimental and clinical data. Int J Hyperth. 2004;20:713–24.

    Article  Google Scholar 

  38. Pacella CM, Bizzarri G, Magnolfi F, Cecconi P, Caspani B, Anelli V, et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients. Radiology. 2001;221:712–20.

    Article  CAS  Google Scholar 

  39. Di Costanzo GG, D’Adamo G, Tortora R, Zanfardino F, Mattera S, Francica G, et al. A novel needle guide system to perform percutaneous laser ablation of liver tumors using the multifiber technique. Acta Radiol. 2013;54:876–81.

    Article  Google Scholar 

  40. Pacella CM, Bizzarri G, Francica G, Bianchini A, De Nuntis S, Pacella S, et al. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis. J Vasc Interv Radiol. 2005;16:1447–57.

    Article  Google Scholar 

  41. Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella CM. Effectiveness, safety, and local progression are not affected by tumor location. AJR Am J Roentgenol. 2012;199:1393–401.

    Article  Google Scholar 

  42. Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella CM. Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location. AJR Am J Roentgenol. 2012;199:1393–401.

    Article  Google Scholar 

  43. Di Costanzo GG, Francica G, Pacella CM. Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives. World J Hepatol. 2014;6:704–15.

    Article  Google Scholar 

  44. Taslakian B, Georges Sabaaly M, Al-Kutoubi A. Patient evaluation and preparation in vascular and interventional radiology: what every interventional radiologist should know (part 1: patient assessment and laboratory tests). Cardiovasc Intervent Radiol. 2016;39:325–33.

    Article  Google Scholar 

  45. Babaei Jandaghi A, Lebady M, Zamani AA. A randomized clinical trial to compare coaxial and noncoaxial techniques in percutaneous core needle biopsy of renal parenchyma. Cardiovasc Intervent Radiol. 2017;40:106–11.

    Article  Google Scholar 

  46. Chunduri S, Whittier WL, Korbert SM. Adequacy and complication rates with 14- vs. 16-gaude automated needles in percutaneous renal biopsy of native kidneys. Semin Dial. 2015;28:E11–!4.

    Article  Google Scholar 

  47. Corapi KM, Chen JL, Balk EM, Gordon CE. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis. 2012;60:62–73.

    Article  Google Scholar 

  48. Sartori S, Mauri G, Tombesi P, Di Vece F, Bianchi L, Pacella CM. Ultrasound-guided laser ablation is safe and effective in the treatment of small renal tumors in patients at increased bleeding risk. Int J Hyperth. 2018;11:1–7. https://doi.org/10.1080/02656736.2018.1468038.

    Article  Google Scholar 

  49. Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria—a 10-year update. J Vasc Interv Radiol. 2014;25:1691–705, e4.

    Article  Google Scholar 

  50. Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. CIRSE quality assurance document and standards for classification of complications: the CIRSE classification system. Cardiovasc Intervent Radiol. 2017;40:1141–6.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Interventional Ultrasound, St. Anna Hospital, Ferrara, Italy

    Sergio Sartori, Paola Tombesi & Francesca Di Vece

  2. Department of Diagnostic Imaging and Interventional Radiology, Regina Apostolorum Hospital, Albano Laziale, Rome, Italy

    Claudio Maurizio Pacella

  3. Department of Ultrasound, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

    Qiyu Zhao

  4. Division of Interventional Radiology, European Institute of Oncology, IRCCS, Milan, Italy

    Giovanni Mauri

Authors
  1. Sergio Sartori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paola Tombesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesca Di Vece
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claudio Maurizio Pacella
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qiyu Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giovanni Mauri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sergio Sartori .

Editor information

Editors and Affiliations

  1. Department of Interventional Radiology, Ospedale Regina Apostolorum, Albano Laziale, Rome, Italy

    Claudio Maurizio Pacella

  2. Department of Ultrasound, Zhejiang University, Hangzhou, China

    Tian'an Jiang

  3. Division of Interventional Radiology, European Institute of Oncology, IRCCS, Milan, Italy

    Giovanni Mauri

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sartori, S., Tombesi, P., Di Vece, F., Pacella, C.M., Zhao, Q., Mauri, G. (2020). Kidney Tumors Laser Ablation. In: Pacella, C., Jiang, T., Mauri, G. (eds) Image-guided Laser Ablation. Springer, Cham. https://doi.org/10.1007/978-3-030-21748-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21748-8_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21747-1

  • Online ISBN: 978-3-030-21748-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation